Dr. Bhargava is an Associate Professor of Neurology at Johns Hopkins University School of Medicine. After obtaining his medical degree from Christian Medical College in Vellore, India, Dr. Bhargava moved to the United States where he completed his neurology residency at Southern Illinois University School of Medicine. His passion for neuroimmunology led him to a three-year fellowship at Johns Hopkins, focusing on Multiple Sclerosis (MS) clinical care and research, supported by a Sylvia Lawry Physician Fellowship from the National MS Society.
Dr. Bhargava's research primarily explores the progression of multiple sclerosis (MS), with a particular interest in the role of meningeal inflammation. He leads the Bhargava Laboratory at Johns Hopkins, where groundbreaking research is conducted on leptomeningeal inflammation using ultra-high field MRI, identification of biomarkers from CNS cell-derived extracellular vesicles, and the effects of metabolites on glial cells. His lab is at the forefront of translational research, participating in clinical trials aimed at developing new treatments for MS.
In addition to his focus on inflammation, Dr. Bhargava is deeply involved in metabolomics studies, examining lipids and small molecule metabolites in serum and plasma to identify new biomarkers that could enhance the diagnosis and prognosis of MS. These efforts also aid in monitoring the efficacy of various interventions and in personalizing treatment plans for MS patients.
Dr. Bhargava's contributions to the field of neurology and MS research have been recognized through several honors, including the Harry Weaver Neuroscience Scholar Award and the John F. Kurtzke Clinician Scientist Development Award from the American Academy of Neurology. His research has also received support from the National MS Society, Race to Erase MS and the American Academy of Neurology.
As a member of the American Academy of Neurology, Dr. Bhargava remains a key figure in the ongoing fight against multiple sclerosis, striving to improve patient outcomes through his dedication to research and patient care at Johns Hopkins Medicine.
